Table 1.
Characteristics of the patients included in the study.
| Patients with CD (n = 31) | Patients with UC (n = 9) | Healthy donors (n = 44) | |
|---|---|---|---|
| Age (years) (mean) | 39 | 33 | 31 |
| Sex (M/F) | 16/15 | 2/7 | 26/18 |
| Disease location (Montréal classification) | L1 n = 5 | E1 n = 0 | |
| L2 n = 1 | E2 n = 6 | ||
| L3 n = 25 | E3 n = 3 | ||
| L4 n = 4 | |||
| P n = 7 | |||
| Ongoing treatments | |||
| 5-AZA | 3 | 1 | |
| Corticosteroids | 3 | 3 | |
| Immunosuppressors | 3 | 3 | |
| Anti-TNF | 16 | 7 | |
| Clinical activity (active/remission) | 11/20 | 3/6 | |
| Crohn's Disease Activity Index (active/remission) | 221/84, 3 | n.a. | |
| Partial Mayo Clinic score (active/remission) | n.a. | 4·3/1·5 | |
| CRP (active/remission) | 45, 8/8, 1 | 20·1/<3 | |
| Endoscopy | 18 | 5 | |
| Surgery (yes/no) | 16/15 | 0/9 | |
CD = Crohn's disease; UC = ulcerative colitis; TNF = tumour necrosis factor; CRP = C-reactive protein; AZA = azathioprine; n.a. = not applicable; M/F = male/female.